Diverse Mechanisms in Immune Activation by Hemocyanins – a Key to Formation of a Potent Immune Response

2016 ◽  
Vol 1 (1) ◽  
pp. 01-03
Author(s):  
Vera Gesheva
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Kenji Maeda ◽  
Nobuyo Higashi-Kuwata ◽  
Noriko Kinoshita ◽  
Satoshi Kutsuna ◽  
Kiyoto Tsuchiya ◽  
...  

AbstractWhile there are various attempts to administer COVID-19-convalescent plasmas to SARS-CoV-2-infected patients, neither appropriate approach nor clinical utility has been established. We examined the presence and temporal changes of the neutralizing activity of IgG fractions from 43 COVID-19-convalescent plasmas using cell-based assays with multiple endpoints. IgG fractions from 27 cases (62.8%) had significant neutralizing activity and moderately to potently inhibited SARS-CoV-2 infection in cell-based assays; however, no detectable neutralizing activity was found in 16 cases (37.2%). Approximately half of the patients (~ 41%), who had significant neutralizing activity, lost the neutralization activity within ~ 1 month. Despite the rapid decline of neutralizing activity in plasmas, good amounts of SARS-CoV-2-S1-binding antibodies were persistently seen. The longer exposure of COVID-19 patients to greater amounts of SARS-CoV-2 elicits potent immune response to SARS-CoV-2, producing greater neutralization activity and SARS-CoV-2-S1-binding antibody amounts. The dilution of highly-neutralizing plasmas with poorly-neutralizing plasmas relatively readily reduced neutralizing activity. The presence of good amounts of SARS-CoV-2-S1-binding antibodies does not serve as a surrogate ensuring the presence of good neutralizing activity. In selecting good COVID-19-convalescent plasmas, quantification of neutralizing activity in each plasma sample before collection and use is required.


2008 ◽  
Vol 83 (2) ◽  
pp. 572-583 ◽  
Author(s):  
Mareike Meythaler ◽  
Amanda Martinot ◽  
Zichun Wang ◽  
Sarah Pryputniewicz ◽  
Melissa Kasheta ◽  
...  

ABSTRACT In contrast to pathogenic lentiviral infections, chronic simian immunodeficiency virus (SIV) infection in its natural host is characterized by a lack of increased immune activation and apoptosis. To determine whether these differences are species specific and predicted by the early host response to SIV in primary infection, we longitudinally examined T-lymphocyte apoptosis, immune activation, and the SIV-specific cellular immune response in experimentally infected rhesus macaques (RM) and sooty mangabeys (SM) with controlled or uncontrolled SIV infection. SIVsmE041, a primary SIVsm isolate, reproduced set-point viremia levels of natural SIV infection in SM but was controlled in RM, while SIVmac239 replicated to high levels in RM. Following SIV infection, increased CD8+ T-lymphocyte apoptosis, temporally coinciding with onset of SIV-specific cellular immunity, and elevated plasma Th1 cytokine and gamma interferon-induced chemokine levels were common to both SM and RM. Different from SM, SIV-infected RM showed a significantly higher frequency of peripheral blood activated CD8+ T lymphocytes despite comparable magnitude of the SIV-specific gamma interferon enzyme-linked immunospot response. Furthermore, an increase in CD4+ and CD4−CD8− T-lymphocyte apoptosis and plasma tumor necrosis factor-related apoptosis-inducing ligand were observed only in RM and occurred in both controlled SIVsmE041 and uncontrolled SIVmac239 infection. These data suggest that the “excess” activated T lymphocytes in RM soon after SIV infection are predominantly of non-virus-specific bystander origin. Thus, species-specific differences in the early innate immune response appear to be an important factor contributing to differential immune activation in natural and nonnatural hosts of SIV infection.


2020 ◽  
Vol 2 (8) ◽  
pp. 3494-3506
Author(s):  
Dong-qun Liu ◽  
Shuai Lu ◽  
Lun Zhang ◽  
Ling-xiao Zhang ◽  
Mei Ji ◽  
...  

Schematic illustration of the LDH nanoparticle-coated yeast shell vaccine and immune activation.


Vaccine ◽  
2011 ◽  
Vol 29 (31) ◽  
pp. 4897-4902 ◽  
Author(s):  
David N. Taylor ◽  
John J. Treanor ◽  
Cynthia Strout ◽  
Casey Johnson ◽  
Theresa Fitzgerald ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-5 ◽  
Author(s):  
Mami Chihara ◽  
Miki Kurita ◽  
Yuki Yoshihara ◽  
Akihiko Asahina ◽  
Koichi Yanaba

Signaling through coinhibitory receptors downregulates the immune response to prevent excessive immune activation and maintain optimal immunity and tolerance. The aim of this study was to examine the levels of the soluble forms of coinhibitory receptors and their ligands, namely, galectin-9 (the ligand of T-cell immunoglobulin and mucin domain 3) and CD155 (the ligand of T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain), and their association with clinical features in patients with systemic sclerosis (SSc). The serum levels of galectin-9 and soluble sCD155 were examined by enzyme-linked immunosorbent assays in patients with SSc, and the results were evaluated with respect to clinical features. Patients with SSc exhibited raised serum levels of galectin-9, but not sCD155. Serum galectin-9 levels were raised not only in patients with diffuse cutaneous SSc but also in patients with limited cutaneous SSc. Furthermore, serum galectin-9 levels correlated positively with the erythrocyte sedimentation rate. In addition, increased serum galectin-9 levels tended to be associated with higher mortality and serious organ involvement. These results suggest that galectin-9, but not CD155, may be involved in the pathogenesis of SSc. In addition, the measurement of serum galectin-9 levels could be used to predict serious organ involvement and high mortality in patients with SSc.


Vaccine ◽  
2000 ◽  
Vol 19 (7-8) ◽  
pp. 992-997 ◽  
Author(s):  
Santiago Dueñas-Carrera ◽  
Liz Alvarez-Lajonchere ◽  
Julio C. Alvarez-Obregón ◽  
Antonieta Herrera ◽  
Lázaro J. Lorenzo ◽  
...  

2011 ◽  
Vol 4 (8) ◽  
pp. 1285-1295 ◽  
Author(s):  
Guo-Zhen Wang ◽  
Xu-Dong Tang ◽  
Mu-Han Lü ◽  
Jin-Hua Gao ◽  
Guang-Ping Liang ◽  
...  

2008 ◽  
Vol 86 (8) ◽  
pp. 834-842 ◽  
Author(s):  
Péter László Pap ◽  
Csongor István Vágási ◽  
Gábor Árpád Czirják ◽  
Zoltán Barta

We investigated the effects of nutritional limitation, humoral immune activation, and their interaction on postnuptial molting of aviary-kept house sparrows ( Passer domesticus (L., 1758)). In a 2 × 2 experimental design, we measured the progress of molting and the quality of feathers produced during molting by house sparrows exposed to different diet qualities (high and low) and humoral immune activation with sheep red blood cells (SRBC). Food quality, but not the activation of humoral immunity, affected significantly the body mass and the process of molting. Sparrows feeding on low-quality food had decreased body mass and longer molts than the high-quality group. Low-quality food, but not the activation of humoral immunity, reduced significantly the length and mass (i.e., the quality) of primaries grown during molting. Birds responded significantly to injection with SRBC compared with the control group, but the immune response was similar between nutritional groups. The absence of a negative effect of humoral immunity on molting in house sparrows might be related to the low energy and nutritional requirements of mounting and maintaining a humoral immune response.


Sign in / Sign up

Export Citation Format

Share Document